Christian Heidbreder
Chief Tech/Sci/R&D Officer bei INDIVIOR PLC
Vermögen: 2 Mio $ am 31.03.2024
Profil
Christian Heidbreder is currently the Chief Scientific Officer at Indivior PLC since 2014.
He is also a Professor at the Medical College of Virginia.
Previously, he worked as the Global Director-Research & Development at Reckitt Benckiser Pharmaceuticals, Inc. He completed his undergraduate, graduate, and doctorate degrees from the Université Catholique de Louvain.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INDIVIOR PLC
0,07% | 06.03.2024 | 92 922 ( 0,07% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Christian Heidbreder
| Unternehmen | Position | Beginn |
|---|---|---|
| INDIVIOR PLC | Chief Tech/Sci/R&D Officer | 01.12.2014 |
| Medical College of Virginia | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Christian Heidbreder
| Unternehmen | Position | Ende |
|---|---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
 Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Corporate Officer/Principal | - |
Ausbildung von Christian Heidbreder
| Université Catholique de Louvain | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Reckitt Benckiser Pharmaceuticals, Inc.
Reckitt Benckiser Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reckitt Benckiser Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products are used to treat chronic relapsing disease of opioid dependence. The company was founded in 2003 and is headquartered in Richmond, VA. | Health Technology |
